Lowering Cholesterol

Join us for a special webcast: “Rethinking Cholesterol”

Gregory Curfman, MD

Assistant Professor of Medicine, former editor-in-chief, Harvard Health Publishing

If the latest information on health and wellness is important to you, you will not want to miss a special live-streamed webcast, “Rethinking Cholesterol,” which will be aired on Thursday, September 24, from 12:30pm to 1:30pm Eastern time. The webcast, which is free to all viewers, is co-sponsored by Reuters, Harvard Health Publishing, the Harvard T.H. Chan School of Public Health, and Harvard Medical School.

Cholesterol guidelines update: controversy over heart risk calculator

Howard LeWine, M.D.

Chief Medical Editor, Harvard Health Publishing

It’s been a topsy-turvy few days in the world of heart health and disease. Last week, the American Heart Association and American College of Cardiology released new guidelines that upended previous recommendations for who should take a cholesterol-lowering statin. A few days later, two Harvard physicians challenged the accuracy of the calculator included in the guidelines, saying it would cause many people to unnecessarily take a statin. The story made headlines in The New York Times and prompted a closed-door review by the guidelines committee. The controversy over the calculator should serve to improve this tool. Adoption of the guidelines should help prevent more heart attacks, strokes, and premature deaths. It’s important to keep in mind that guidelines are just that—information to guide a decision, not to mandate it. The best approach is to talk about what’s best for you with a trusted physician.